S
Sharps Technology
Sharps Technology is an innovative medical device company
About Sharps Technology
Sharps Technology specializes in the development and manufacturing of advanced safety syringes designed to eliminate accidental needlestick injuries, prevent needle reuse, and reduce medicine waste. Operating within the global healthcare market, the company addresses critical issues such as the syringe shortage forecasted by the World Health Organization (WHO). Sharps Technology serves healthcare providers and institutions, offering patented products that comply with US regulatory and WHO guidelines. The business model focuses on partnering with healthcare organizations to deliver practical solutions to pressing healthcare challenges, thereby generating revenue through the sale of its innovative syringe products. The company's production facility is ISO certified, FDA cleared, and holds CE mark approval, ensuring high standards of quality and safety. Sharps Technology is listed on NASDAQ under the ticker STSS, and it aims to enhance shareholder value through exceptional business performance and responsible communication.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2018
- Headquarters
- New York City, United States
- Listing
- IPO 2022
- Employees
- 12
- Open positions
- None listed
- Dealroom signal
- 78.6/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| PRIVATE PLACEMENT VCOther financing | Aug 2025 | $400M | — | Saba Capital Management · ParaFi Capital · Pantera Capital | ↗ |
| POST IPO EQUITYOther financing | Jan 2025 | $20M | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $204K | 0% | −$114M | -56090.3% |
| 2025 | $204K | — | −$114M | -56090.3% |
| 2024 | $0 | — | −$12M | — |
| 2023 | $0 | — | −$9.4M | — |
| 2022 | $0 | — | −$14M | — |
| 2021 | $0 | — | −$4.5M | — |
| 2020 | $0 | — | −$2.3M | — |
Growth signals
Latest recorded traffic for Sharps Technology is 2.2K monthly website visits, up 4.8% over the last three months. Sharps Technology's team grew 9.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors3 additional known investors
Pantera Capital
ParaFi Capital
Saba Capital Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sharps Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sharps Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.